| Iron in heart failure: friend or foe? | |
| | |
MedLine Citation:
|
PMID: 20424991 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Qurat-ul-ain Jelani; Stuart D Katz |
Publication Detail:
|
Type: Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: Current heart failure reports Volume: 7 ISSN: 1546-9549 ISO Abbreviation: Curr Heart Fail Rep Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-05-25 Completed Date: 2010-10-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101196487 Medline TA: Curr Heart Fail Rep Country: United States |
Other Details:
|
Languages: eng Pagination: 49-51 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Leon H. Charney Division of Cardiology, New York University Langone Medical Center, New York, NY 10016, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anemia, Iron-Deficiency
/
etiology* Biological Markers Double-Blind Method Female Ferric Compounds / administration & dosage* Heart Failure / blood*, complications Hemoglobins / analysis* Humans Iron / blood* Male Maltose / administration & dosage, analogs & derivatives* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Ferric Compounds; 0/Hemoglobins; 0/ferric carboxymaltose; 69-79-4/Maltose; 7439-89-6/Iron |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Testosterone Deficiency and Exercise Intolerance in Heart Failure: Treatment Implications.
Next Document: Pharmacoepigenetics in Heart Failure.